Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Washington D.C. DC, Columbus OH, Charlotte NC,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase3, Recruiting
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
for
Breast Neoplasm Female, Early Detection of Cancer,
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: Female
Age: 18 - 70+
Code: NCT06892275
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Chapel Hill NC,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07029581
Phase2, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Washington D.C. DC, Philadelphia PA, Manhasset NY,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Washington D.C. DC, Fairfax VA, Charlottesville VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase2, Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for
Familial Adenomatous Polyposis (FAP)
Location: Washington D.C. DC, Baltimore MD, Danville PA,
Sponsor: Rapamycin Holdings Inc.
Sex: All
Age: 18+
Code: NCT06950385
Phase3, Recruiting
PREVENT ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06581861
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase1, Phase2, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase2, Recruiting
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
for
Breast Cancer
Location: Washington D.C. DC, Philadelphia PA, Boston MA,
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT04841148
Phase2, Recruiting
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Washington D.C. DC, Fairfax VA, Louisville KY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07407933
Phase1, Phase2, Recruiting
Nilotinib in Huntington's Disease
for
Huntington Disease
Location: Washington DC
Sponsor: Georgetown University
Sex: All
Age: 25 - 70+
Code: NCT03764215
Phase1, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Washington D.C. DC, Fairfax VA, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase1, Phase2, Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Washington D.C. DC, Philadelphia PA, Pittsburgh PA,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Mindful Self-Compassion for Anxiety Disorders and Depression
for
Anxiety Disorders, Generalized Anxiety Disorder,
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 18 - 70+
Code: NCT05671419
Recruiting
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
for
Periprosthetic Joint Infections
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Elute, Inc.
Sex: All
Age: 22+
Code: NCT05361941
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase3, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: Washington D.C. DC, Philadelphia PA, New Brunswick NJ,